Publications by authors named "Laszlo Radvanyi"

87Publications

COVID-19: a pandemic experience that illuminates potential reforms to health research.

EMBO Mol Med 2020 Sep 30:e13278. Epub 2020 Sep 30.

Department of Paediatrics, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.15252/emmm.202013278DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7536940PMC
September 2020

Targeting the cancer mutanome of breast cancer.

Nat Med 2018 06;24(6):703-704

Ontario Institute for Cancer Research, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41591-018-0065-zDOI Listing
June 2018

Combination Therapy with NHS-muIL12 and Avelumab (anti-PD-L1) Enhances Antitumor Efficacy in Preclinical Cancer Models.

Clin Cancer Res 2017 Oct 5;23(19):5869-5880. Epub 2017 Jul 5.

Immuno-Oncology Translational Innovation Platform, EMD Serono Research and Development Institute, Billerica, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-17-0483DOI Listing
October 2017

IL2 Variant Circumvents ICOS+ Regulatory T-cell Expansion and Promotes NK Cell Activation.

Cancer Immunol Res 2016 11 3;4(11):983-994. Epub 2016 Oct 3.

Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2326-6066.CIR-15-0195DOI Listing
November 2016

Defective STAT1 activation associated with impaired IFN-γ production in NK and T lymphocytes from metastatic melanoma patients treated with IL-2.

Oncotarget 2016 Jun;7(24):36074-36091

Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.8683DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094984PMC
June 2016

Tumor-Infiltrating Lymphocyte Therapy: Addressing Prevailing Questions.

Cancer J 2015 Nov-Dec;21(6):450-64

From the Department of Immunology, H. Lee Moffitt Cancer Center; and Lion Biotechnologies, Tampa, FL.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/journalppo/2015/11000/Tumor_Inf
Web Search
http://dx.doi.org/10.1097/PPO.0000000000000162DOI Listing
September 2016

Triggering co-stimulation directly in melanoma tumor fragments drives CD8 tumor-infiltrating lymphocyte expansion with improved effector-memory properties.

Oncoimmunology 2015 Dec 1;4(12):e1040219. Epub 2015 Jul 1.

Department of Immunology; H. Lee Moffitt Cancer Center ; Tampa, FL USA ; Lion Biotechnologies ; Tampa, FL USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/2162402X.2015.1040219DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4635692PMC
December 2015

BTLA marks a less-differentiated tumor-infiltrating lymphocyte subset in melanoma with enhanced survival properties.

Oncoimmunology 2015 Aug 16;4(8):e1014246. Epub 2015 Mar 16.

Department of Melanoma Medical Oncology; The University of Texas MD Anderson Cancer Center ; Houston, TX USA ; Lion Biotechnologies ; Tampa, FL USA ; Department of Immunology; H Lee Moffitt Cancer Center ; Tampa, FL USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/2162402X.2015.1014246DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4570103PMC
August 2015

PD-L1 expression and prognostic impact in glioblastoma.

Neuro Oncol 2016 Feb 30;18(2):195-205. Epub 2015 Aug 30.

Departments of Neurosurgery, The University of Texas M.D. Anderson Cancer Center, Houston, Texas (E.K.N., J.W., N.K.Y., N.H., L.-Y.K., K.G., X.L., A.B.H.); Department of Biostatistics, The University of Texas M.D. Anderson Cancer Center, Houston, Texas (S.Z.); Center for RNA Interference and Non-Coding RNAs, The University of Texas M.D. Anderson Cancer Center, Houston, Texas (C.I.); Flow Cytometry and Cell Imaging Core Facility, The University of Texas M.D. Anderson Cancer Center, Houston, Texas (J.K.B.); Neuropathology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas (G.N.F.); Department of Experimental Therapeutics, The University of Texas M.D. Anderson Cancer Center, Houston, Texas (G.A.C.); Neuro-Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas (C.A.C.); Melanoma Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas (C.C., K.R.); Lion Biotechnologies, Woodland Hills, California (J.Q.C., L.R.); Dept. of Immunology, H. Lee Moffitt Cancer Center, Tampa, Florida (J.Q.C., L.R.).

View Article

Download full-text PDF

Source
http://neuro-oncology.oxfordjournals.org/content/early/2015/
Web Search
http://neuro-oncology.oxfordjournals.org/lookup/doi/10.1093/
Publisher Site
http://dx.doi.org/10.1093/neuonc/nov172DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4724183PMC
February 2016

Multicystic dedifferentiated retroperitoneal liposarcoma: tumour cyst fluid analysis and implications for management.

BMJ Case Rep 2015 Jul 8;2015. Epub 2015 Jul 8.

Department of Surgery, Section of Surgical Oncology, Keck School of Medicine, University of Southern California, Los Angeles, CA Sarcoma Program, Hoag Family Cancer Institute and Hoag Memorial Hospital Presbyterian, Newport Beach, CA.

View Article

Download full-text PDF

Source
http://casereports.bmj.com/lookup/doi/10.1136/bcr-2015-21121
Publisher Site
http://dx.doi.org/10.1136/bcr-2015-211218DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4499720PMC
July 2015

BRAFV600E Co-opts a Conserved MHC Class I Internalization Pathway to Diminish Antigen Presentation and CD8+ T-cell Recognition of Melanoma.

Cancer Immunol Res 2015 Jun 20;3(6):602-9. Epub 2015 Mar 20.

Department of Melanoma Medical Oncology, Center for Cancer Immunology Research, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Immunology, Center for Cancer Immunology Research, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2326-6066.CIR-15-0030DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4457616PMC
June 2015

Analysis of the intratumoral adaptive immune response in well differentiated and dedifferentiated retroperitoneal liposarcoma.

Sarcoma 2015 29;2015:547460. Epub 2015 Jan 29.

Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA ; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2015/547460DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4326351PMC
February 2015

Peptide-based vaccination and induction of CD8+ T-cell responses against tumor antigens in breast cancer.

BioDrugs 2015 Feb;29(1):15-30

Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s40259-014-0114
Web Search
http://link.springer.com/10.1007/s40259-014-0114-1
Publisher Site
http://dx.doi.org/10.1007/s40259-014-0114-1DOI Listing
February 2015

Manipulating the tumor microenvironment ex vivo for enhanced expansion of tumor-infiltrating lymphocytes for adoptive cell therapy.

Clin Cancer Res 2015 Feb 3;21(3):611-21. Epub 2014 Dec 3.

Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. The Immunology Program of the University of Texas Health Science Center, Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Immunology, H. Lee Moffitt Cancer Center, Tampa, Florida. Lion Biotechnologies, Woodland Hills, Los Angeles, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-14-1934DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315752PMC
February 2015

Cytotoxicity of human endogenous retrovirus K-specific T cells toward autologous ovarian cancer cells.

Clin Cancer Res 2015 Jan 4;21(2):471-83. Epub 2014 Nov 4.

Department of Veterinary Sciences, Michale E. Keeling Center for Comparative Medicine and Research, The University of Texas MD Anderson Cancer Center, Houston, Texas. Graduate School of Biomedical Sciences, The University of Texas Health Science Center at Houston, Houston, Texas. Viral Oncology Program, SRI International, Menlo Park, California. Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-14-0388DOI Listing
January 2015

Activation and propagation of tumor-infiltrating lymphocytes on clinical-grade designer artificial antigen-presenting cells for adoptive immunotherapy of melanoma.

J Immunother 2014 Nov-Dec;37(9):448-60

*Department of Melanoma Medical Oncology †Division of Pediatrics, MD Anderson Cancer Center, Houston, TX ‡Infectious Disease and Immunogenetics Section, Department of Transfusion Medicine, Clinical Center and trans-NIH Center for Human Immunology, National Institutes of Health, Bethesda, MD ∥Lion Biotechnologies, Woodland Hills, CA §Sidra Medical and Research Hospital, Doha, Qatar.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CJI.0000000000000056DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4199393PMC
November 2015

The IL-2 cytokine family in cancer immunotherapy.

Cytokine Growth Factor Rev 2014 Aug 1;25(4):377-90. Epub 2014 Aug 1.

Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Lion Biotechnologies, Woodland Hills, CA 91367, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S13596101140008
Publisher Site
http://dx.doi.org/10.1016/j.cytogfr.2014.07.018DOI Listing
August 2014

Tumor-infiltrating lymphocyte therapy for melanoma: rationale and issues for further clinical development.

BioDrugs 2014 Oct;28(5):421-37

Department of Melanoma Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Box 904, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40259-014-0097-yDOI Listing
October 2014

Continuous 4-1BB co-stimulatory signals for the optimal expansion of tumor-infiltrating lymphocytes for adoptive T-cell therapy.

Oncoimmunology 2013 Sep 3;2(9):e25581. Epub 2013 Jul 3.

Department of Melanoma Medical Oncology; The University of Texas MD Anderson Cancer Center; Houston, TX USA ; The Immunology Program of the University of Texas Health Science Center, Graduate School of Biomedical Sciences; The University of Texas MD Anderson Cancer Center; Houston, TX USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/onci.25581DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3850170PMC
September 2013

Antagonist antibodies to PD-1 and B7-H1 (PD-L1) in the treatment of advanced human cancer--letter.

Clin Cancer Res 2013 Oct 18;19(19):5541. Epub 2013 Sep 18.

Authors' Affiliations: Department of Melanoma Medical Oncology, University of Texas, MD Anderson Cancer Center, Houston, Texas; and Cutaneous Oncology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-1054DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3823378PMC
October 2013

Immunotherapy exposes cancer stem cell resistance and a new synthetic lethality.

Authors:
Laszlo Radvanyi

Mol Ther 2013 Aug;21(8):1472-4

Department of Melanoma Medical Oncology, University of Texas, MD Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/mt.2013.160DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3740219PMC
August 2013

New insights on the role of CD8(+)CD57(+) T-cells in cancer.

Oncoimmunology 2012 Sep;1(6):954-956

Department of Melanoma Medical Oncology; University of Texas M.D. Anderson Cancer Center; Houston, TX USA ; University of Texas Graduate School of Biomedical Sciences; Houston, TX USA ; University of Texas Medical School at Houston; Houston, TX USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/onci.20307DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3489757PMC
September 2012

Harnessing the power of the immune system to target cancer.

Annu Rev Med 2013 22;64:71-90. Epub 2012 Oct 22.

Department of Melanoma Medical Oncology, The Center for Cancer Immunology Research, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://www.annualreviews.org/doi/10.1146/annurev-med-112311-
Publisher Site
http://dx.doi.org/10.1146/annurev-med-112311-083918DOI Listing
July 2013

Spleen cells from young donors eradicate large tumors--letter.

Authors:
Laszlo Radvanyi

Clin Cancer Res 2012 Nov 15;18(21):6074-5; author reply 6076. Epub 2012 Oct 15.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-12-2369DOI Listing
November 2012

Advances in the development of cancer immunotherapies.

Trends Immunol 2013 Feb 30;34(2):90-8. Epub 2012 Sep 30.

Center for Cancer Immunology Research, GU and Melanoma Medical Oncology Department, MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.it.2012.08.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3565019PMC
February 2013

PD-1 and BTLA and CD8(+) T-cell "exhaustion" in cancer: "Exercising" an alternative viewpoint.

Oncoimmunology 2012 Aug;1(5):735-738

Department of Melanoma Medical Oncology; University of Texas; MD Anderson Cancer Center; Houston, TX USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/onci.20823DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3429577PMC
August 2012

PD-1 blockade enhances T-cell migration to tumors by elevating IFN-γ inducible chemokines.

Cancer Res 2012 Oct 20;72(20):5209-18. Epub 2012 Aug 20.

Department of Melanoma Medical Oncology, The Center for Cancer Immunology Research, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://cancerres.aacrjournals.org/cgi/doi/10.1158/0008-5472.
Publisher Site
http://dx.doi.org/10.1158/0008-5472.CAN-12-1187DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3476734PMC
October 2012

A new approach to simultaneously quantify both TCR α- and β-chain diversity after adoptive immunotherapy.

Clin Cancer Res 2012 Sep 3;18(17):4733-42. Epub 2012 Jul 3.

Department of Melanoma Medical Oncology, Unit 904, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-11-3234DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3823368PMC
September 2012

Advances in the treatment of metastatic melanoma: adoptive T-cell therapy.

Semin Oncol 2012 Apr;39(2):215-26

Department of Melanoma Medical Oncology, The University of Texas, M.D. Anderson Cancer Center, Houston, TX 77054, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2012.01.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3500663PMC
April 2012

BRAF(V600) inhibitor GSK2118436 targeted inhibition of mutant BRAF in cancer patients does not impair overall immune competency.

Clin Cancer Res 2012 Apr 21;18(8):2326-35. Epub 2012 Feb 21.

Department of Investigational Cancer Therapeutics, Phase I Clinical Trials Program, Division of Cancer Medicine, MD Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-11-2515DOI Listing
April 2012

White paper on adoptive cell therapy for cancer with tumor-infiltrating lymphocytes: a report of the CTEP subcommittee on adoptive cell therapy.

Clin Cancer Res 2011 Apr 15;17(7):1664-73. Epub 2011 Feb 15.

Moffitt Cancer Center & Research Institute, 12902 Magnolia Drive, Tampa, FL 33612, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-10-2272DOI Listing
April 2011

Melanoma cells express ICOS ligand to promote the activation and expansion of T-regulatory cells.

Cancer Res 2010 Dec 23;70(23):9581-90. Epub 2010 Nov 23.

Department of Immunology, The University of Texas, M. D. Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-10-1379DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3058814PMC
December 2010

Molecular anatomy of breast cancer stroma and its prognostic value in estrogen receptor-positive and -negative cancers.

J Clin Oncol 2010 Oct 30;28(28):4316-23. Epub 2010 Aug 30.

Department of Breast Medical Oncology, Unit 1354, The University of Texas M. D. Anderson Cancer Center, PO Box 301439, Houston,TX 77230-1439, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2009.27.2419DOI Listing
October 2010

2E8 binds to the high affinity I-domain in a metal ion-dependent manner: a second generation monoclonal antibody selectively targeting activated LFA-1.

J Biol Chem 2010 Oct 19;285(43):32860-8. Epub 2010 Aug 19.

Section of Transplantation Immunology, Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center,Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M110.111591DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2963386PMC
October 2010

Development and application of 'phosphoflow' as a tool for immunomonitoring.

Expert Rev Vaccines 2010 Jun;9(6):631-43

Department of Melanoma Medical Oncology, The University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/erv.10.59DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2933839PMC
June 2010

TGF-beta1 induces preferential rapid expansion and persistence of tumor antigen-specific CD8+ T cells for adoptive immunotherapy.

J Immunother 2010 May;33(4):371-81

Department of Melanoma Medical Oncology, University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CJI.0b013e3181cd1180DOI Listing
May 2010

MART-1-specific melanoma tumor-infiltrating lymphocytes maintaining CD28 expression have improved survival and expansion capability following antigenic restimulation in vitro.

J Immunol 2010 Jan 30;184(1):452-65. Epub 2009 Nov 30.

Department of Melanoma Medical Oncology, Graduate School of Biomedical Sciences, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.0901101DOI Listing
January 2010

Human endogenous retrovirus K triggers an antigen-specific immune response in breast cancer patients.

Cancer Res 2008 Jul;68(14):5869-77

Department of Veterinary Sciences and Michale E. Keeling Center for Comparative Medicine and Research, The University of Texas M. D. Anderson Cancer Center, Houston, TX 78602-6621, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-07-6838DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802396PMC
July 2008

A new approach for the large-scale generation of mature dendritic cells from adherent PBMC using roller bottle technology.

J Immune Based Ther Vaccines 2008 Mar 6;6. Epub 2008 Mar 6.

Department of Melanoma Medical Oncology, University of Texas, M,D, Anderson Cancer Center, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1476-8518-6-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2292722PMC
March 2008

A novel strategy for rapid and efficient isolation of human tumor-specific CD4(+) and CD8(+) T-cell clones.

J Immunol Methods 2008 Feb 9;331(1-2):13-26. Epub 2007 Oct 9.

Department of Lymphoma and Myeloma, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jim.2007.09.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2265521PMC
February 2008

Survivin DNA vaccine generated specific antitumor effects in pancreatic carcinoma and lymphoma mouse models.

Vaccine 2007 Nov 14;25(46):7955-61. Epub 2007 Sep 14.

Department of Gastrointestinal Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.vaccine.2007.08.050DOI Listing
November 2007

HLA-A0201 positive pancreatic cell lines: new findings and discrepancies.

Cancer Immunol Immunother 2007 May 1;56(5):719-24. Epub 2006 Sep 1.

Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-006-0217-8DOI Listing
May 2007

Improving antitumor immune responses by circumventing immunoregulatory cells and mechanisms.

Clin Cancer Res 2006 Aug;12(16):4794-803

Department of Melanoma Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-06-0944DOI Listing
August 2006

Immunosuppression in melanoma immunotherapy: potential opportunities for intervention.

Clin Cancer Res 2006 Apr;12(7 Pt 2):2359s-2365s

Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-05-2537DOI Listing
April 2006

A sensitive flow cytometry-based cytotoxic T-lymphocyte assay through detection of cleaved caspase 3 in target cells.

J Immunol Methods 2005 Sep;304(1-2):43-59

Immunology Platform, Aventis Pasteur Research and Development, Connaught Campus Toronto, Ontario, Canada M2R 3T4.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jim.2005.06.005DOI Listing
September 2005

Effect of serum and antioxidants on the immunogenicity of protein kinase C-activated chronic lymphocytic leukemia cells.

J Immunother 2005 Jan-Feb;28(1):28-39

Division of Molecular and Cellular Biology, Research Institute, Sunnybrook and Women's College Health Sciences Center, 2075 Bayview Avenue, Toronto, Canada M4N 3M5.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00002371-200501000-00004DOI Listing
August 2005

Anti-carcinoembryonic antigen immunity.

Cancer Chemother Biol Response Modif 2003 ;21:299-325

Aventis Pasteur, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0921-4410(03)21015-2DOI Listing
September 2004

Discovery and immunologic validation of new antigens for therapeutic cancer vaccines.

Authors:
Laszlo Radvanyi

Int Arch Allergy Immunol 2004 Feb 5;133(2):179-97. Epub 2004 Feb 5.

Immunology Platform, Aventis Pasteur Canada, Toronto, Ont, Canada.

View Article

Download full-text PDF

Source
https://www.karger.com/Article/FullText/76625
Publisher Site
http://dx.doi.org/10.1159/000076625DOI Listing
February 2004